Project Description

7481 patients (18%) had young-onset diabetes, with age at diagnosis of mean 32.9 years [SD 5.7] versus 53.9 years [9.0] with late-onset diabetes (n=33 548) Young-onset diabetes patients had longer disease duration (median 10 years [IQR 3-18]) than those with late-onset diabetes (5 years [2-11]) Fewer patients with young-onset diabetes achieved HbA1c concentrations lower than 7% compared to those with late-onset diabetes (27% vs. 42%; p < 0.0001) Patients with young-onset diabetes had higher mean concentrations of HbA1c , LDL cholesterol and a higher prevalence of retinopathy than those with late-onset diabetes, but were less likely to receive Statins (2347 [31%] vs. 12 441 [37%]; p < 0.0001) and Renin-angiotensin-system inhibitors (1868 [25%] vs. 9665 [29%]; p=0.006) Conclusion: One in five adult patients had young-onset diabetes in clinic-based settings across Asia. Compared with patients with late-onset diabetes, metabolic control in those with young-onset diabetes was poor and fewer received organ-protective drugs. Explanation:
This says that the risk is greater in people having early onset of diabetes. So if people keep a check on their lifestyle and avoid acquiring any disease in younger age then this is good for their long life.